mRNA |
elocalcitol |
CTRPv2 |
pan-cancer |
AAC |
-0.087 |
0.01 |
mRNA |
silmitasertib |
CTRPv2 |
pan-cancer |
AAC |
-0.095 |
0.01 |
mRNA |
Tipifarnib |
GDSC1000 |
pan-cancer |
AAC |
0.086 |
0.01 |
mRNA |
piperlongumine:MST-312 (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.085 |
0.01 |
mRNA |
Doxorubicin |
gCSI |
pan-cancer |
AAC |
-0.12 |
0.02 |
mRNA |
sirolimus:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.08 |
0.02 |
mRNA |
BRD-K33514849 |
CTRPv2 |
pan-cancer |
AAC |
0.28 |
0.02 |
mRNA |
CD-437 |
CTRPv2 |
pan-cancer |
AAC |
0.075 |
0.02 |
mRNA |
JQ-1 |
GDSC1000 |
pan-cancer |
AAC |
0.077 |
0.02 |
mRNA |
L-685458 |
CCLE |
pan-cancer |
AAC |
-0.11 |
0.02 |